Plné znění - 2/2008 Sb. m. s.

Ministerstvo xxxxxxxxxxxx xxxx sděluje, že xxx 16. xxxxxxxxx 2007 bylo xxxxxxxxxx xxxxxxxxx XXXXXX, depozitářem Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx¹⁾, xxxxxxxx schválení xxxxxx xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx xxxxx x xxxxx xxxxxxx.

Xxxxxxx X xxxxxxxxx x xxxxxxxx x xxxxxxx x článkem 34 xxxx. 3 Xxxxxx xxx 1. xxxxx 2008 x tímto xxxx xxxxxxxxx x xxxxxxxx i xxx Xxxxxx republiku. Dnem xxxxxx Přílohy I x xxxxxxxx xxxxxxxx xxxxxx Xxxxxxx I Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx sportu xx xxxxx pro xxx 2007, vyhlášená xxx x. 59/2007 Xx. x. s.

Xxxxxxxx xxxxx Přílohy X x xxxx xxxxxxx do českého xxxxxx se vyhlašují xxxxxxxx.

X1. ANABOLICKÉ XXXXX

Xxxxxxxxxx látky xxxx xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX XXXXXXXX (XXX):

x. Xxxxxxxx * XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-androstendion (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-xxxxxxxxxxxxxxxx); xxxxxxxxxx; xxxxxxxx; xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx (17α-ethynyl-17β-hydroxyandrost-4-eno[2,3-d]isoxazol); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); desoxymethyltestosteron (17α-metyl-5α-androst-2-en-17β-ol); xxxxxxxxxxx; xxxxxxxxxxxxx (19-nor-17α-pregn-4-en-17-ol); xxxxxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); xxxxxxxxx; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; xxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; metandienon (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9-dien-3-on); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); methylnortestosteron (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9,11-xxxxx-3-xx); methyltestosteron; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); norboleton; xxxxxxxxxxxxxx; xxxxxxxxxxxx; xxxxxxxx; oxandrolon; xxxxxxxxxxx; oxymetolon; prostanozol ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); xxxxxxxxx; xxxxxxxxxx; xxxxxxxxx; 1-testosteron (17β-xxxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxx (18α-homo-pregna-4,9,11-trien-17β-ol-3-on); xxxxxxxxx x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky.

x. Xxxxxxxxx ** XXX:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, DHEA), xxxxxxxxxxx x xxxxxxxxxxx metabolity x isomery:

5α-androstan-3α,17α-diol androst-5-en-3β,17α-diol

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (androst-4-en-3β,17β-diol)

5α-xxxxxxxxx-3β,17α-xxxx 5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)

5α-xxxxxxxxx-3β,17β-xxxx xxx-xxxxxxxxxxxxxxxxxx

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

androst-5-en-3β,17α-diol 19-norandrosteron

xxxxxxx-5-xx-3α,17α-xxxx 19-xxxxxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17β-xxxx

X xxxxxxxxx, xxx xxxx xxxx xxxxxxxxxx androgenní xxxxxxxxxx xxxxxxx přirozeně, xxxx se mít xx xx, že Xxxxxx xxxxxxxx tuto Xxxxxxxxx látku x xxxx hlášen pozitivní Xxxxxxxxx xxxxxxxxxxx nález, xxxx xx koncentrace Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx nebo xxxxxxxxxxx x/xxxx když xx xxxxxxxx jiný xxxxxxxxx poměr xx Xxxxxx Sportovce xxxxxxxx xxxxxxxxx xx rozmezí xxxxxx, xxxxx se xxxxxxxx xxxxxxxxx x xxxx tak, xx xxxxxxxxxx normální xxxxxxxxx xxxxxxxx. Xxxxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx x xxxxxxx případě, pokud Xxxxxxxxx prokáže, že xx koncentrace Zakázané xxxxx xxxx xxxxxx xxxxxxxxxx nebo xxxxxxxxxx x/xxxx xxxxxxxxx xxxxx xx Xxxxxx Xxxxxxxxx xxxxxxxx fyziologickým xxxx xxxxxxxxxxxx stavem.

Xxxx xx mít za xx, že Xxxxxx Xxxxxxxxx obsahuje Xxxxxxxxx xxxxx x xxxxxxxxx xxxxxxx Pozitivní xxxxxxxxxxx xxxxx xx xxxxx xxxxxxxxx x xxx xxxxxxxxx koncentraci, xxxxx xxx xxxxx spolehlivé xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxx, že xx Zakázaná xxxxx xxxxxxxxxx xxxxxx. X xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

Xxxx xx xxxxxxx xxxxxxxx analýzy xxxxxxxx xxxxxxxxxxx xx xxxxxxx hodnot, xxxxx xx xxxxxxxx xxxxxxxxx x lidí x xxxxx spolehlivá xxxxxxxxxx xxxxxx (xxxx. IRMS) xxxxxxxxxxx xxxxxxxx původ Xxxxxxxx xxxxx, xxx xxxxxxxx známky xxxxxxx Xxxxxxxx látky, jako xxxx. xxxxxxxxx x xxxxxxxxxxx referenčními xxxxxxxxxxx xxxxxxx, xxxx když xxxxxxxxx xxxxxxxxx poměr X/X xxxxx xxx xxxxx (4) ku xxxxx (1) x xxxxx spolehlivá xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx, provede xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx xxxxx xxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxxx testů xxxx xxxxxxxxxx xxxxxxxxxx testů.

Xx-xx vyžadováno takové xxxxx xxxxxxx, pak xxxxxxxx xxxx laboratoří xxxxxx xxxx neobvyklý x xx xxxx xxxxxxxxx. Xxxxx xxxxxxxxx xxxxxxx, xx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx xxxxx Zakázané xxxxx, xxxx nutné xxxxxxxx xxxxx šetření, a xxxx xx mít xx to, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx. Xxxxx xxxxxx xxxxxxx spolehlivá analytická xxxxxx (např. XXXX) x xxxxxx x xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx xxxxx, xxxx xxxxxxx longitudinální xxxxxx Xxxxxxxxx xxx, xx xxxx xxxxxxxxxx Xxxxxxxxxxxxxx xxxxxxxxxx x následujících 3 měsících xxxxxxx xxxxxxxx xxx xxxxxxxxxxx xxxxxxxx. Xxxxxxxx, xxxxx xxxxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxx, bude hlášen xxxx xxxxxxxxx. Pokud xxxxxxxxxxxxxx profil Sportovce, xxxxxxxx xxxxxxxxxx xxxxx, xxxx fyziologicky xxxxxxxx, xxxx se pak xxxxxxxxx xx Pozitivní xxxxxxxxxxx nález.

V xxxxxxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxxx xxxx xxx x xxxx xxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx xxxxxx ve xxxxxx xxxxxx koncentracích (ng/ml). Xxxxx xxxxxxxxx xxxxxx xxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx látky, xxxx xxx provedeno xxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxx (xxxxxxxxxx xxxxx).

Xxxxx xxxxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx 19-xxxxxxxxxxxxxxx, xxxx xx xx považovat xx xxxxxxx a přesvědčivý xxxxx xxxxxxxxxx xxxxxx Xxxxxxxx xxxxx. V xxxxxxx xxxxxxx není xxxxx xxxxxxxx xxxxx xxxxxxx.

X xxxxxxx, xx Xxxxxxxxx nebude xxxxxxxxxxxxx xxx dalších xxxxxxxxx, xxxx se xxx xx to, xx Xxxxxx Xxxxxxxxx xxxxxxxx Zakázanou látku.

2. Xxxxxxx anabolické xxxxx, xxxxxxxxxx:

Klenbuterol, xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX), tibolon, xxxxxxx, xxxxxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx.

X2. XXXXXXX X XXXXXXXX XXXXX

Xxxxxxxxxxx xxxxx x jejich xxxxxxxxxx xxxxxxx xxxx zakázány:

1. Xxxxxxxxxxxx (XXX);

2. Růstový xxxxxx (xXX), xxxxxxxx xxxxxxx xxxxxxx faktory (xxxx. XXX-1), xxxxxxxxxx xxxxxxx xxxxxxx (XXX);

3. Xxxxxxxxxxxxx (xxxx. XX, xXX), zakázané xxx x xxxx;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx.

Pokud Xxxxxxxxx nemůže prokázat, xx xxxxxxxxxxx xxxx xxxxxxxxx fyziologickým či xxxxxxxxxxxx stavem, xxxx xx xxx xx xx, že Xxxxxx xxxxxxxx Zakázanou látku (xxx xx uvedeno xxxx) x případech, xxx xxxxxxxxxxx Xxxxxxxx xxxxx nebo xxxxxx xxxxxxxxxx xx xxxxxxxxxx x/xxxx xxxxxxxxx poměry xx Xxxxxx Xxxxxxxxx xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx zjištěné u xxxx tak, xx xxxxxxxxxxxx normální endogenní xxxxxxxx.

Pokud laboratoř xxxxxxxxx, po xxxxx xxxxxxxxxx analytické metody, xx Xxxxxxxx xxxxx xx exogenního původu, xxxx xx mít xx xx, že Xxxxxx obsahuje Zakázanou xxxxx a xxxx xxxxxxx Pozitivní xxxxxxxxxxx xxxxx.

X3. XXXX-2 AGONISTÉ

Xxxxxxx xxxx-2 agonisté včetně xxxxxx X- x X-xxxxxxx xxxx xxxxxxxx.

Xxxxxxxx jsou xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxxx, pro xxxxx xx xxx xxxxxxxx xxxxx xxxxxxx zkrácené xxxxxxxxxxxx xxxxxxx.

X xxxx xxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxx, xxxx xxxxx xxxxxxxxxxx (volný plus xxxxxxxxxx) xxxxx než 1000 xxxxxxxxx x 1 xxxxxxxxx xxxx xxxxxxxxx xx Pozitivní xxxxxxxxxxx xxxxx, pokud Xxxxxxxxx neprokáže, xx xxxxxxxxxx xxxxxxxx byl xxxxxxxx xxxxxxxxxxxxx užíváním xxxxxxxxxxx v xxxxxxxx.

X4. XXXXXXXXXXX X XXXXXXXXXX XXXXXXX

Xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Inhibitory xxxxxxxx, xxxxxxxxxx:

2. Xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxxx:

3. Xxxxxxx xxxxxxxxxxxxxx látky xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx.

X5. DIURETIKA X XXXXXXX MASKOVACÍ XXXXX

Xxxxxxxxx látky xxxx xxxxxxxx. Xxxxxxxx:

Xxxxxxxxx*, xxxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx alfa-reduktázy (xxxx. xxxxxxxxxx, xxxxxxxxxx), xxxxxxxxxxxxxxx (xxxx. xxxxxxx, dextran, xxxxxxxxxxxxxxxxx) x další xxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxx xxxxxxxx:

Acetazolamid, amilorid, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, kyselina xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), triamteren x další xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx xxxxxx (kromě xxxxxxxxxxxx, který xxxx xxxxxxxx).

* Terapeutická xxxxxxx xxxx platná, xxxxx xxx Xxxxxxxxx xxxxxxxx diuretika ve xxxxxxx x prahovou xxxx podprahovou hladinou xxxx Xxxxxxxx látky (xxxxx).

X1. XXXXXXXXX XXXXXXX XXXXXXX

Xxxxxxxx je xxxxxxxxxxx:

X2. XXXXXXXX X XXXXXXXXX XXXXXXXXXX

X3. XXXXXX XXXXXX

Xxxxxxxxxxxxxx xxxxxxx xxxxx, xxxx, xxxxxxxx xxxxxxxx, nebo xxxxxxxxxx xxxxxxx genů, xxxxx mají xxxxxxxxx xxxxxx sportovní výkon, xx zakázané.

X6. STIMULANCIA

Xxxxxxx xxxxxxxxxxx (xxxxxx xxxx xxxxxx xxxxxxxxxx xxxxxxxxx (X- x X-) xxxxxxx) jsou xxxxxxxx, x xxxxxxxx derivátů xxxxxxxxx x případě xxxxxx xxxxxxxx užití x xxxxxxxxxxx zahrnutých xx Xxxxxxxxxxxxxx xxxxxxxx xxx rok 2008.

Xxxxxxxxxxx zahrnují:

Adrafinil, xxxxxxxxx**, amfepramon, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxxx, bromantan, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxxx****, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, fenetylin, xxxxxxxxxxx, xxxxxxxxxxx, fenkamin, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, 4-xxxxxxxxxxxxxx (xxxxxxxx), xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxx***, xxxxxxxxxxx, xxxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxx (D-), xxxxxxxxxxxx****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, parahydroxyamfetamin, xxxxxxx, xxxxxxxxxxx, p-methylamfetamin, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, tuaminoheptan x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx xxxxxxxxx xxxxxxxx xxxx xxxxxxxx x xxxxx xxxxxx bude xxxxxxxxxx xx xxxxxxxxxxx xxxxx pouze, xxxxx Xxxxxxxxx xxxxxxx, xx xxxx xxxxxxxxx xxxxxxxxxx x běžných léčebných xxxxxxxxxxx umožňuje xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxx xx x xxx menší xxxxxxxxxxxxxxx, xx bude xxxxxxx xxxxxxxx xxxx xxxxxxxxx xxxxx.

X7. XXXXXXXXX

Následující xxxxxxxxx xxxx xxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), xxxxxxxx x xxxx xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx.

X8. XXXXXXXXXXX

Xxxxxxxxxxx (xxxx. xxxxx, xxxxxxxxx) jsou xxxxxxxx.

X9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxxxx, xxxxxxxx, xxxxxxxxxx nebo xxxxxxxxxxxxx xxxxxxxx xxxx xxxxxxxx. Xxxxxx užití vyžaduje xxxxxxxxxxxxx xxxxxxx.

Xxxx xxxxxxx injekční aplikace (xxxxxxxxxxxx, do xxxxx xxxxxx, xx xxxxx xxxxxx, xxxxxxxxxx, xx xxxx) a xxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxx uvedených.

Xxxxxxx přípravky xxxxxxxx xx potíže xxxxx (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), xxxx, xxxxx, xxxx, potíže xxxxx xxxxxxx xxxxxx, xxxxxxxx xxx x xxxxx xxxxxx xxxxxxxx x xxxxxxxxxx žádnou xxxxx terapeutické xxxxxxx.

X1. XXXXXXX

Xxxxxxx (xxxxxx) xx xxxxxxxx xxxxx Xxx xxxxxxx v xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx xxxx provádět xxxxxxxx xxxxxxxx x/xxxx xxxxxxxx krve. Xxxxxxx xxxxxxx pro xxxxxxxx xxxxxxxxxxx xxxxxxxx (xxxxxxxxxxxxx xxxxxxx) xx xxx xxxxxx xxxxxxxx uvedena x xxxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (XXX) (0.10 x/x)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxx x xxxxxxxxxxxx (XXX) (0.20 x/x)

∙ Lukostřelba (XXXX, XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxxx (XXXX) xxx xxx xxxxxxxxxx xx střelbou (0.10 x/x)

∙ Xxxxxxxxxxx xxxxx (XXX) (0.10 g/l)

∙ Xxxxx motorismus (XXX) (0.30 x/x)

∙ Xxxxxxx (IPC) (0.10 x/x)

X2. XXXX-XXXXXXXXX

Xxxxx xxxx xxxxx xxxxxx, xxxx-xxxxxxxxx jsou xxxxxxxx xxxxx Xxx xxxxxxx x xxxxxxxxxxxxx sportech.

∙ Xxxxxxxxxxxx sport (XXX)

∙ Xxxxxxxx (XXXX)

∙ Xxxx (XXXX)

∙ Bridž (XXX)

∙ Xxxxxxx (XXX)

∙ Gymnastika (XXX)

∙ Jachting (XXXX) - "xxxxx xxxx" - xxx xxxxxxxxxxx

∙ Xxxxxxx (XXX)

∙ Xxxxxxx xxxxxx x xxxxxxxxxxxx (XXX)

∙ Xxxxxxxxxxx (XXXX, IPC) (xxxxxxxx xxxx Mimo xxxxxx)

∙ Xxxxxxxx (XXX) - xxxxx xx xxxxxx a akrobatické xxxxxxxx-xxxxx x U-rampa, x xxxxxxxxx X-xxxxx x "xxx air"

∙ Xxxxxxx xxxxxxx (XXXX) - xxx xxxxxxxxxx se xxxxxxxx

∙ Xxxxxxxxxxx sport (XXX)

∙ Xxxxxxxx x xxxxxxx xxxxxx (XXXX, XXX "xxxxx")

∙ Xxxxxxx (XXXX, XXX) (xxxxxxxx také Xxxx xxxxxx)

∙ Xxxxx xxxxxxxxxx (XXX)

∙ Zápas (XXXX)

Xxxx-xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxx:

Xxxxxxxxxx, xxxxxxxxxx, xxxxxxxx, betaxolol, bisoprolol, xxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxx, metoprolol, xxxxxxx, oxprenolol, xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxxx, xxx ne x xxxxxxxx xxxxx na xx

"Xxxxxxxxxx xxxxx"* xxxx xxxxxxxxxxx xxxx:

∙ Xxxxxxx Xxxx-2 xxxxxxxx x xxxxxxxx, xxxxx xxxxxxxxxxx (volného xxxx xxxxxxxxxxx) xxx xxxxxxxx xxxxxx xxx 1000 xx/xx xxxx x clenbuterolu (xxxxxxx xx xxxxxxx X 1.2 Xxxxxxx anabolické xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, probenecid;

∙ Xxxxx, kropropamid, krotetamid, xxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, haptaminol, isomethepten, xxxxxxxxxxxxxxx, xxxxxxxxxxxx, p-metylamfetamin, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, ortetamin, oxilofrin, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxx x xxxxxxx xxxxxxx stimulancia xxxxxxxxx xxxxxxxx x xxxxxx X6, pro xxxxx Xxxxxxxxx xxxxxxx, že xxxxxxx xxxxxxxx xxxxxxx x xxxxxx X6;

∙ Kanabinoidy;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Všechny Xxxx-xxxxxxxxx.

*"V Xxxxxxx xxxxx být xxxxxxxxxxx xxxxxxxxxx xxxxx, xxxxx xxxxxxxx umožňuji xxxxxxxxx xxxxxxxx antidopingových xxxxxxxx, xxxxxxx jsou všeobecně xxxxxxxx v xxxxxxx xxxxxxxxx xxxxxxxxxxx, xxxx x xxxxx xx xxxxx xxxxxxxxxxxxxxx, že xxxxx xxxxxxx xxxxxxxx xxxx xxxxxxxxx xxxxxxx." Xxxxxxxx antidopingového xxxxxxxx xxxxxxxxxx takovéto xxxxx xxxx znamenat xxxxxxx xxxxxx xx předpokladu, xx "...Sportovec xxxx xxxxx xxxxxxxx, xx Xxxxxxx xxxxxxxxxx xxxxx xxxxxx xxxxxxxxx xx xxxxxxx xxxxxxxxxxx xxxxxx...".

Xxxxxx xxxxxxx x. 2/2008 Sb. x. x. nabyl xxxxxxxxx xxxx 31.1.2008.

Xxxxxx předpis č. 2/2008 Xx. x. x. xxx xxxxxx xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x xxxxxxxxx xx 7.2.2009.

Znění xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx předpisů x xxxxxxxx není xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx shora uvedeného xxxxxxxx xxxxxxxx.